Initial Experience and Early Results of Mitral Valve Repair with Cardiocel Pericardial Patch.
CONCLUSIONS: Initial results of the CardioCel patch in mitral valve repair surgery are satisfactory. The resistance to infection and late degeneration will need to be assessed in the future. PMID: 29885979 [PubMed - as supplied by publisher]
ConclusionMVr is an attractive option for specific patients with IE and does not seem to negatively impact on relapses.
Publication date: January 2019Source: Archives of Cardiovascular Diseases Supplements, Volume 11, Issue 1Author(s): Marie Leauthier, A. Riberi, N. Resseguier, C. Lavoute, A.C. Casalta, J. Pradier, J.P. Casalta, F. Gouriet, D. Raoult, M. Drancourt, V. Gariboldi, F. Collart, G. HabibBackground and ObjectivesIn native mitral valve infective endocarditis (NMVIE), the respective values of mitral valve repair (MVR) and mitral valve replacement (MVRP) are still debated. We compared MVR and MVRP in a large prospective series of pts operated on for NMVIE in La Timone Hospital, Marseille.MethodsBetween 2010 and 2017, 151 pts with NM...
IN THE UNITED STATES, intraoperative transesophageal echocardiography (TEE) is a class I recommendation by the American Heart Association and American College of Cardiology in mitral valve repair1 and infective endocarditis,1 and is a suggested standard practice1-4 in all open cardiac valve repair and replacement surgeries by the Society of Cardiovascular Anesthesiologists, Society of Thoracic Surgeons, and American Society of Echocardiography.5,6 In addition to cardiac valve surgery, TEE is an agreed upon standard in open aortic surgery7 and a “rescue” imaging modality in any surgical case with refractory hemodynamic instability.
ConclusionThe intermediate-term outcomes of our original chordal replacement technique were not inferior to those in previous reports, although a 26 mm annuloplasty was found to be associated with a higher mitral valve gradient at rest.
ConclusionsIt was feasible and safe to use ValveClamp to perform a catheter ‐mediated edge‐to‐edge mitral valve repair in a porcine model. This system is potentially applicable as a novel user‐friendly system for the treatment of MR.
Authors: Zhou D, Pan W, Jilaihawi H, Zhang G, Feng Y, Pan X, Liu J, Yu S, Cao Q, Ge J Abstract AIMS: To assess the safety and efficacy of the Venus p-valve. METHODS AND RESULTS: Patients who had moderate or severe pulmonary regurgitation after surgical repair of the right ventricular outflow tract (RVOT) with a transannular or RVOT patch were included in the study. Fifty-five patients (67% female; average age 28.7±12.4 years) from 6 different hospitals in China were enrolled. The procedure success rate was 98.2%. One patient experienced valve dislodgement two days after the procedure. During the 12-month...
ConclusionThe CLAS score is highly predictive of a successful repair. We thus propose that, in the patients with a score of ≤ 8, repair should always be attempted irrespective of the pathology. The patients expected to be scored> 8 should be referred to a repair reference center.
ConclusionsInitial results with the CardioCel patch in mitral valve repair operations were satisfactory. The resistance to infection and late degeneration will need to be assessed in the future.
Publication date: September 2018Source: The Annals of Thoracic Surgery, Volume 106, Issue 3Author(s): Bobby Yanagawa, Malak Elbatarny, Subodh Verma, Samantha Hill, Amine Mazine, John D. Puskas, Jan O. FriedrichBackgroundThis meta-analysis compares the early and late outcomes of valve repair versus replacement, the primary surgical strategies for tricuspid valve infective endocarditis (IE).MethodsWe searched MEDLINE and EMBASE databases until 2016 for studies comparing tricuspid valve repair and replacement.ResultsThe main outcomes were mortality, recurrent IE, and need for reoperation. There were 12 unmatched retrospective...
ConclusionsTricuspid valve endocarditis patients who undergo tricuspid valve excision, repair, and replacement have similar 30-day operative mortality, as defined by The Society of Thoracic Surgeons. Excision patients have significantly lower unplanned readmission rates at 1 year. Tricuspid valvectomy is an acceptable initial treatment in this high-risk group as part of a surgical strategy to identify patients who are candidates for eventual valve replacement. Further study of long-term outcomes and survival is warranted.